5AX3
Crystal structure of ERK2 complexed with allosteric and ATP-competitive inhibitors.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PHOTON FACTORY BEAMLINE BL-17A |
Synchrotron site | Photon Factory |
Beamline | BL-17A |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2013-12-14 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.98 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 43.835, 66.465, 116.871 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 43.886 - 2.984 |
R-factor | 0.2387 |
Rwork | 0.236 |
R-free | 0.28460 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2fys |
RMSD bond length | 0.003 |
RMSD bond angle | 0.753 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | MOLREP |
Refinement software | PHENIX ((phenix.refine: 1.9_1692)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 43.890 | 3.160 |
High resolution limit [Å] | 2.980 | 2.980 |
Rmerge | 0.080 | 0.693 |
Number of reflections | 13356 | |
<I/σ(I)> | 14.7 | 2.25 |
Completeness [%] | 99.5 | 97.9 |
Redundancy | 3.9 | 3.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 5.5 | 277 | PEG3350, Sodium chloride |